nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Neck stiffness—Arformoterol—chronic obstructive pulmonary disease	0.0227	0.0227	CcSEcCtD
Gadoteridol—Neck stiffness—Formoterol—chronic obstructive pulmonary disease	0.0227	0.0227	CcSEcCtD
Gadoteridol—Abdominal cramps—Aminophylline—chronic obstructive pulmonary disease	0.021	0.021	CcSEcCtD
Gadoteridol—Nuchal rigidity—Formoterol—chronic obstructive pulmonary disease	0.0208	0.0208	CcSEcCtD
Gadoteridol—Nuchal rigidity—Arformoterol—chronic obstructive pulmonary disease	0.0208	0.0208	CcSEcCtD
Gadoteridol—Gingivitis—Tiotropium—chronic obstructive pulmonary disease	0.017	0.017	CcSEcCtD
Gadoteridol—Injection site pain—Formoterol—chronic obstructive pulmonary disease	0.0132	0.0132	CcSEcCtD
Gadoteridol—Injection site pain—Arformoterol—chronic obstructive pulmonary disease	0.0132	0.0132	CcSEcCtD
Gadoteridol—Musculoskeletal stiffness—Formoterol—chronic obstructive pulmonary disease	0.012	0.012	CcSEcCtD
Gadoteridol—Musculoskeletal stiffness—Arformoterol—chronic obstructive pulmonary disease	0.012	0.012	CcSEcCtD
Gadoteridol—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.0107	0.0107	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.0106	0.0106	CcSEcCtD
Gadoteridol—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.0103	0.0103	CcSEcCtD
Gadoteridol—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.00989	0.00989	CcSEcCtD
Gadoteridol—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.0091	0.0091	CcSEcCtD
Gadoteridol—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.0087	0.0087	CcSEcCtD
Gadoteridol—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00862	0.00862	CcSEcCtD
Gadoteridol—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00838	0.00838	CcSEcCtD
Gadoteridol—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00838	0.00838	CcSEcCtD
Gadoteridol—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00788	0.00788	CcSEcCtD
Gadoteridol—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00781	0.00781	CcSEcCtD
Gadoteridol—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00673	0.00673	CcSEcCtD
Gadoteridol—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.0066	0.0066	CcSEcCtD
Gadoteridol—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00625	0.00625	CcSEcCtD
Gadoteridol—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00602	0.00602	CcSEcCtD
Gadoteridol—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00599	0.00599	CcSEcCtD
Gadoteridol—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.0058	0.0058	CcSEcCtD
Gadoteridol—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00559	0.00559	CcSEcCtD
Gadoteridol—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.00554	0.00554	CcSEcCtD
Gadoteridol—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00546	0.00546	CcSEcCtD
Gadoteridol—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00543	0.00543	CcSEcCtD
Gadoteridol—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00543	0.00543	CcSEcCtD
Gadoteridol—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00537	0.00537	CcSEcCtD
Gadoteridol—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00532	0.00532	CcSEcCtD
Gadoteridol—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00526	0.00526	CcSEcCtD
Gadoteridol—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00524	0.00524	CcSEcCtD
Gadoteridol—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00519	0.00519	CcSEcCtD
Gadoteridol—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00513	0.00513	CcSEcCtD
Gadoteridol—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00513	0.00513	CcSEcCtD
Gadoteridol—Cough—Tiotropium—chronic obstructive pulmonary disease	0.0051	0.0051	CcSEcCtD
Gadoteridol—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00506	0.00506	CcSEcCtD
Gadoteridol—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00504	0.00504	CcSEcCtD
Gadoteridol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00501	0.00501	CcSEcCtD
Gadoteridol—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00497	0.00497	CcSEcCtD
Gadoteridol—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00497	0.00497	CcSEcCtD
Gadoteridol—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00486	0.00486	CcSEcCtD
Gadoteridol—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00482	0.00482	CcSEcCtD
Gadoteridol—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00478	0.00478	CcSEcCtD
Gadoteridol—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00478	0.00478	CcSEcCtD
Gadoteridol—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00477	0.00477	CcSEcCtD
Gadoteridol—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00477	0.00477	CcSEcCtD
Gadoteridol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00475	0.00475	CcSEcCtD
Gadoteridol—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00475	0.00475	CcSEcCtD
Gadoteridol—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00472	0.00472	CcSEcCtD
Gadoteridol—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00469	0.00469	CcSEcCtD
Gadoteridol—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00462	0.00462	CcSEcCtD
Gadoteridol—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00462	0.00462	CcSEcCtD
Gadoteridol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0045	0.0045	CcSEcCtD
Gadoteridol—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00442	0.00442	CcSEcCtD
Gadoteridol—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00442	0.00442	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00438	0.00438	CcSEcCtD
Gadoteridol—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00437	0.00437	CcSEcCtD
Gadoteridol—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00437	0.00437	CcSEcCtD
Gadoteridol—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00436	0.00436	CcSEcCtD
Gadoteridol—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00433	0.00433	CcSEcCtD
Gadoteridol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Gadoteridol—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00425	0.00425	CcSEcCtD
Gadoteridol—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00425	0.00425	CcSEcCtD
Gadoteridol—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00417	0.00417	CcSEcCtD
Gadoteridol—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00413	0.00413	CcSEcCtD
Gadoteridol—Cough—Formoterol—chronic obstructive pulmonary disease	0.00411	0.00411	CcSEcCtD
Gadoteridol—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00411	0.00411	CcSEcCtD
Gadoteridol—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00407	0.00407	CcSEcCtD
Gadoteridol—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00407	0.00407	CcSEcCtD
Gadoteridol—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00403	0.00403	CcSEcCtD
Gadoteridol—Cough—Montelukast—chronic obstructive pulmonary disease	0.00403	0.00403	CcSEcCtD
Gadoteridol—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.00403	0.00403	CcSEcCtD
Gadoteridol—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Gadoteridol—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00401	0.00401	CcSEcCtD
Gadoteridol—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00401	0.00401	CcSEcCtD
Gadoteridol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00401	0.00401	CcSEcCtD
Gadoteridol—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Gadoteridol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Gadoteridol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Gadoteridol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Gadoteridol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Gadoteridol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Gadoteridol—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00397	0.00397	CcSEcCtD
Gadoteridol—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00397	0.00397	CcSEcCtD
Gadoteridol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00393	0.00393	CcSEcCtD
Gadoteridol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00393	0.00393	CcSEcCtD
Gadoteridol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00392	0.00392	CcSEcCtD
Gadoteridol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00391	0.00391	CcSEcCtD
Gadoteridol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00388	0.00388	CcSEcCtD
Gadoteridol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00385	0.00385	CcSEcCtD
Gadoteridol—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00385	0.00385	CcSEcCtD
Gadoteridol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00385	0.00385	CcSEcCtD
Gadoteridol—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00385	0.00385	CcSEcCtD
Gadoteridol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Gadoteridol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00379	0.00379	CcSEcCtD
Gadoteridol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00379	0.00379	CcSEcCtD
Gadoteridol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00378	0.00378	CcSEcCtD
Gadoteridol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00377	0.00377	CcSEcCtD
Gadoteridol—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00377	0.00377	CcSEcCtD
Gadoteridol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00377	0.00377	CcSEcCtD
Gadoteridol—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Gadoteridol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00372	0.00372	CcSEcCtD
Gadoteridol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00371	0.00371	CcSEcCtD
Gadoteridol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Gadoteridol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Gadoteridol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0036	0.0036	CcSEcCtD
Gadoteridol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0036	0.0036	CcSEcCtD
Gadoteridol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00358	0.00358	CcSEcCtD
Gadoteridol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Gadoteridol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Gadoteridol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Gadoteridol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00346	0.00346	CcSEcCtD
Gadoteridol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00343	0.00343	CcSEcCtD
Gadoteridol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00343	0.00343	CcSEcCtD
Gadoteridol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Gadoteridol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Gadoteridol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Gadoteridol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00334	0.00334	CcSEcCtD
Gadoteridol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00329	0.00329	CcSEcCtD
Gadoteridol—Pain—Formoterol—chronic obstructive pulmonary disease	0.00329	0.00329	CcSEcCtD
Gadoteridol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00326	0.00326	CcSEcCtD
Gadoteridol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00324	0.00324	CcSEcCtD
Gadoteridol—Pain—Montelukast—chronic obstructive pulmonary disease	0.00322	0.00322	CcSEcCtD
Gadoteridol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Gadoteridol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Gadoteridol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00318	0.00318	CcSEcCtD
Gadoteridol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Gadoteridol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Gadoteridol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Gadoteridol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00315	0.00315	CcSEcCtD
Gadoteridol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00311	0.00311	CcSEcCtD
Gadoteridol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00306	0.00306	CcSEcCtD
Gadoteridol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00306	0.00306	CcSEcCtD
Gadoteridol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00304	0.00304	CcSEcCtD
Gadoteridol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00304	0.00304	CcSEcCtD
Gadoteridol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00304	0.00304	CcSEcCtD
Gadoteridol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00304	0.00304	CcSEcCtD
Gadoteridol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00303	0.00303	CcSEcCtD
Gadoteridol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Gadoteridol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Gadoteridol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Gadoteridol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Gadoteridol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Gadoteridol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Gadoteridol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00299	0.00299	CcSEcCtD
Gadoteridol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00298	0.00298	CcSEcCtD
Gadoteridol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00298	0.00298	CcSEcCtD
Gadoteridol—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00297	0.00297	CcSEcCtD
Gadoteridol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00293	0.00293	CcSEcCtD
Gadoteridol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Gadoteridol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00287	0.00287	CcSEcCtD
Gadoteridol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00287	0.00287	CcSEcCtD
Gadoteridol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Gadoteridol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Gadoteridol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Gadoteridol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00278	0.00278	CcSEcCtD
Gadoteridol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Gadoteridol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Gadoteridol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00268	CcSEcCtD
Gadoteridol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00267	0.00267	CcSEcCtD
Gadoteridol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00263	0.00263	CcSEcCtD
Gadoteridol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00263	0.00263	CcSEcCtD
Gadoteridol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00258	0.00258	CcSEcCtD
Gadoteridol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00257	0.00257	CcSEcCtD
Gadoteridol—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Gadoteridol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00254	CcSEcCtD
Gadoteridol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00254	CcSEcCtD
Gadoteridol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00249	0.00249	CcSEcCtD
Gadoteridol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00249	0.00249	CcSEcCtD
Gadoteridol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00245	0.00245	CcSEcCtD
Gadoteridol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00245	0.00245	CcSEcCtD
Gadoteridol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00243	0.00243	CcSEcCtD
Gadoteridol—Rash—Formoterol—chronic obstructive pulmonary disease	0.00243	0.00243	CcSEcCtD
Gadoteridol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Gadoteridol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Gadoteridol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Gadoteridol—Headache—Formoterol—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Gadoteridol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Gadoteridol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Gadoteridol—Rash—Montelukast—chronic obstructive pulmonary disease	0.00238	0.00238	CcSEcCtD
Gadoteridol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Gadoteridol—Headache—Montelukast—chronic obstructive pulmonary disease	0.00236	0.00236	CcSEcCtD
Gadoteridol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Gadoteridol—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Gadoteridol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Gadoteridol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Gadoteridol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Gadoteridol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Gadoteridol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Gadoteridol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Gadoteridol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Gadoteridol—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00221	0.00221	CcSEcCtD
Gadoteridol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Gadoteridol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00217	0.00217	CcSEcCtD
Gadoteridol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00216	CcSEcCtD
Gadoteridol—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00208	0.00208	CcSEcCtD
Gadoteridol—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00208	0.00208	CcSEcCtD
Gadoteridol—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00205	0.00205	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00201	0.00201	CcSEcCtD
Gadoteridol—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00198	0.00198	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00187	0.00187	CcSEcCtD
Gadoteridol—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00186	0.00186	CcSEcCtD
Gadoteridol—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00172	0.00172	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00172	0.00172	CcSEcCtD
Gadoteridol—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Gadoteridol—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00166	0.00166	CcSEcCtD
Gadoteridol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00166	0.00166	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00163	CcSEcCtD
Gadoteridol—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Gadoteridol—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.0016	0.0016	CcSEcCtD
Gadoteridol—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00157	CcSEcCtD
Gadoteridol—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00156	0.00156	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.00154	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00151	0.00151	CcSEcCtD
Gadoteridol—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00151	0.00151	CcSEcCtD
Gadoteridol—Shock—Prednisone—chronic obstructive pulmonary disease	0.00149	0.00149	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Gadoteridol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.00138	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Gadoteridol—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Gadoteridol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Gadoteridol—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Gadoteridol—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Gadoteridol—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Gadoteridol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Gadoteridol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Gadoteridol—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Gadoteridol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Gadoteridol—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.001	0.001	CcSEcCtD
Gadoteridol—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000963	0.000963	CcSEcCtD
Gadoteridol—Rash—Prednisone—chronic obstructive pulmonary disease	0.000955	0.000955	CcSEcCtD
Gadoteridol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000954	0.000954	CcSEcCtD
Gadoteridol—Headache—Prednisone—chronic obstructive pulmonary disease	0.000949	0.000949	CcSEcCtD
Gadoteridol—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000899	0.000899	CcSEcCtD
